| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JPS.2600600902 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0022354915380850?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:S0022354915380850?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 4935981 |
| P2093 | author name string | S. Riegelman | |
| W. L. Chiou | |||
| P2860 | cites work | Ibid. | Q951150 |
| The hafnium-iridium system | Q23917350 | ||
| Particle Size of Drugs and Its Relationship to Absorption and Activity | Q39976211 | ||
| Pharmaceutical Applications of Polymorphism | Q39984474 | ||
| The status and future of chemical microscopy | Q40030770 | ||
| Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs | Q47398912 | ||
| Complication in Using Rabbits for the Study of Oral Drug Absorption | Q51685708 | ||
| Inhibition of Sulfathiazole Crystal Growth by Polyvinylpyrrolidone | Q53009371 | ||
| Plastic crystals: A historical review | Q59885560 | ||
| Dissolution characteristics of reserpine-polyvinylpyrrolidone co-precipitates | Q68739045 | ||
| Complexation Between Hexylresorcinol and Polyvinylpyrrolidone and Its Microbiological Evaluation | Q69891540 | ||
| Determination of the Degree of Crystallinity in Solid-Solid Equilibria | Q71231243 | ||
| Oral Absorption of Griseofulvin in Dogs: Increased Absorption via Solid Dispersion - in Polyethylene Glycol 6000 | Q71458372 | ||
| Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate | Q72243313 | ||
| Quantitative analysis of pharmaceutical preparations by X-ray diffractometry. IX. Direct quantitative X-ray diffraction analysis of salicylic acid plaster | Q72457551 | ||
| Desoxycholic Acid Enhancement of Orally Administered Reserpine | Q72798684 | ||
| Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. IV. Chloramphenicol--urea system | Q72813156 | ||
| New method of solid-state dispersion for increasing dissolution rates | Q72922816 | ||
| Study of possible complex formation between macromolecules and certain pharmaceuticals. II. Polyvinylpyrrolidone with p-aminobenzoic acid, aminopyrine, benzoic acid, salicylic acid, p-hydroxybenzoic acid, m-hydroxybenzoic acid, citric acid, and phen | Q73562878 | ||
| Eutectic solidification in metals | Q75718603 | ||
| STUDIES ON THE METHOD OF THERMAL ANALYSIS OF ORGANIC MEDICINALS. III. RELATIONS BETWEEN METHODS OF SAMPLE PREPARATION AND OBTAINED PHASE DIAGRAMS | Q76577256 | ||
| PROPERTIES OF FUSED MANNITOL IN COMPRESSED TABLETS | Q76734695 | ||
| STUDIES ON ABSORPTION OF EUTECTIC MIXTURE. II. ABSORPTION OF FUSED CONGLOMERATES OF CHLORAMPHENICOL AND UREA IN RABBITS | Q76744234 | ||
| STUDIES ON THE METHOD OF THERMAL ANALYSIS OF ORGANIC MEDICINALS. V. SEMI-MICRO APPARATUS FOR THE DIFFERENTIAL THERMAL ANALYSIS PERMITTING DIRECT OBSERVATION | Q77146461 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmaceutical science | Q7180763 |
| dosage form | Q718608 | ||
| P304 | page(s) | 1281-1302 | |
| P577 | publication date | 1971-09-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Pharmaceutical Applications of Solid Dispersion Systems | |
| P478 | volume | 60 |
| Q91867722 | 1H NMR Relaxation Study to Evaluate the Crystalline State of Active Pharmaceutical Ingredients Containing Solid Dosage Forms Using Time Domain NMR |
| Q57351431 | A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems |
| Q97526192 | A Review on Solid Dispersion and Carriers Used Therein for Solubility Enhancement of Poorly Water Soluble Drugs |
| Q52205402 | A calorimetric investigation into the interaction between paracetamol and polyethlene glycol 4000 in physical mixes and solid dispersions. |
| Q44247725 | A compaction process to enhance dissolution of poorly water-soluble drugs using hydroxypropyl methylcellulose |
| Q54342599 | A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine. |
| Q43638520 | A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug. |
| Q35868332 | A menthol-based solid dispersion technique for enhanced solubility and dissolution of sulfamethoxazole from an oral tablet matrix |
| Q44047378 | A new high-performance liquid chromatography (HPLC) method for the analysis of halofantrine (HF) in pharmaceuticals |
| Q82592410 | A novel hemostatic delivery device for thrombin: Biodegradable poly(D,L‐lactide‐co‐glycolide) 50:50 microspheres |
| Q93943369 | A process to produce effervescent tablets: fluidized bed dryer melt granulation |
| Q69404948 | A relationship between diffusional transport in lipid membranes and a lipophilic-eutectic parameter |
| Q35209961 | A study on the impact of hydroxypropyl methylcellulose on the viscosity of PEG melt suspensions using surface plots and principal component analysis. |
| Q42930931 | A thermal analysis method to predict the complete phase diagram of drug–polymer solid dispersions |
| Q57351440 | Ability of Different Polymers to Inhibit the Crystallization of Amorphous Felodipine in the Presence of Moisture |
| Q57377103 | Acceleration of the crystal growth rate of low molecular weight organic compounds in supercooled liquids in the presence of polyhydroxybutyrate |
| Q44135410 | Action of carriers on Carbamazepine dissolution |
| Q93249655 | Albendazole solid dispersions against alveolar echinococcosis: a pharmacotechnical strategy to improve the efficacy of the drug |
| Q42374351 | Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin |
| Q48026439 | Amorphous Solid Dispersion of Meloxicam Enhanced Oral Absorption in Rats With Impaired Gastric Motility |
| Q34233896 | Amorphous pharmaceutical solids: preparation, characterization and stabilization |
| Q38358879 | Amorphous solid dispersions: a robust platform to address bioavailability challenges |
| Q47967797 | Amorphous-Amorphous Phase Separation in API/Polymer Formulations |
| Q44647890 | An Attempt to Stabilize Nilvadipine Solid Dispersion by the Use of Ternary Systems |
| Q74511140 | An investigation of FB interactions with poly(ethylene glycol) 6000, poly(ethylene glycol) 4000, and poly-epsilon-caprolactone by thermoanalytical and spectroscopic methods and modeling |
| Q39526624 | An investigation on the solid dispersions of chlordiazepoxide |
| Q84646465 | Analysis of Amorphous Solid Dispersions Using 2D Solid-State NMR and 1H T1 Relaxation Measurements |
| Q93949433 | Assessment of the extrudability of three different mixtures of saturated polyglycolysed glycerides by determination of the "specific work of extrusion" and by capillary rheometry |
| Q45134862 | Basic drug--enterosoluble polymer coevaporates: development of oral controlled release systems |
| Q83769924 | Bioavailability and in vivo efficacy of a praziquantel-polyvinylpyrrolidone solid dispersion in Schistosoma mansoni-infected mice |
| Q44149142 | Bioavailability of hydrochlorothiazide from isomalt-based moulded tablets |
| Q46851055 | Cefuroxime axetil solid dispersions prepared using solution enhanced dispersion by supercritical fluids |
| Q89910048 | Cellulose based polymers in development of amorphous solid dispersions |
| Q51136853 | Characteristics of bicalutamide solid dispersions and improvement of the dissolution. |
| Q46862731 | Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions |
| Q74065414 | Characterization and evaluation of tenoxicam coprecipitates |
| Q44183545 | Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone |
| Q93104026 | Characterization of Amorphous Solid Dispersion of Pharmaceutical Compound with pH-Dependent Solubility Prepared by Continuous-Spray Granulator |
| Q57353648 | Characterization of amorphous solid dispersions |
| Q41925228 | Characterization of olanzapine-solid dispersions |
| Q41625700 | Characterization of poly(ethylene oxide) as a drug carrier in hot-melt extrusion |
| Q39769144 | Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology |
| Q51751144 | Chemical, pharmaceutical and clinical standardization of the TRUE Test caine mix. |
| Q57376932 | Chiral discrimination by a cellulose polymer: differential crystallization inhibition of enantiomers in amorphous dispersions |
| Q38411322 | Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques |
| Q39172749 | Clinical pharmacokinetics of an amorphous solid dispersion tablet of elacridar |
| Q57094720 | Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors |
| Q64902990 | Co-Amorphous Solid Dispersions for Solubility and Absorption Improvement of Drugs: Composition, Preparation, Characterization and Formulations for Oral Delivery. |
| Q33834542 | Co-crystals: a novel approach to modify physicochemical properties of active pharmaceutical ingredients. |
| Q41989397 | Co-solvent evaporation method for enhancement of solubility and dissolution rate of poorly aqueous soluble drug simvastatin: in vitro-in vivo evaluation |
| Q44148690 | Comparative physicochemical properties of hydrocortisone-PVP composites prepared using supercritical carbon dioxide by the GAS anti-solvent recrystallization process, by coprecipitation and by spray drying. |
| Q78653231 | Comparison between polyvinylpyrrolidone and silica nanoparticles as carriers for indomethacin in a solid state dispersion |
| Q44639623 | Comparison of nanomilling and coprecipitation on the enhancement of in vitro dissolution rate of poorly water-soluble model drug aripiprazole |
| Q41989862 | Comparison of the effect of tromethamine and polyvinylpyrrolidone on dissolution properties and analgesic effect of nimesulide. |
| Q36614773 | Conjugation of Hot-Melt Extrusion with High-Pressure Homogenization: a Novel Method of Continuously Preparing Nanocrystal Solid Dispersions |
| Q42356630 | Construction and Validation of Binary Phase Diagram for Amorphous Solid Dispersion Using Flory-Huggins Theory |
| Q94548025 | Contribution of Crystal Lattice Energy on the Dissolution Behavior of Eutectic Solid Dispersions |
| Q38737132 | Contribution of hot-melt extrusion technology to advance drug delivery in the 21st century |
| Q57378177 | Controlled Release of a Poorly Water-Soluble Drug from Hot-Melt Extrudates Containing Acrylic Polymers |
| Q24301733 | Controlled release systems containing solid dispersions: strategies and mechanisms |
| Q43119928 | Crystal engineering to improve physicochemical properties of mefloquine hydrochloride. |
| Q47807784 | DNP-enhanced solid-state NMR spectroscopy of active pharmaceutical ingredients |
| Q47569867 | Design and evaluation of bi-layer pump tablet of flurbiprofen solid dispersion for zero-order controlled delivery |
| Q39962816 | Design and optimization of diclofenac sodium controlled release solid dispersions by response surface methodology |
| Q44558850 | Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method. |
| Q73367839 | Design, optimization and evaluation of domperidone coevaporates |
| Q58109405 | Development and Evaluation of a Water Soluble Fluorometholone Eye Drop Formulation Employing Polymeric Micelle |
| Q41989615 | Development and characterization of zaleplon solid dispersion systems: a technical note |
| Q38922261 | Development and evaluation of solid dispersion of spironolactone using fusion method |
| Q34769107 | Development of a mini-tablet of co-grinded prednisone-Neusilin complex for pediatric use |
| Q77486241 | Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy |
| Q68081951 | Development of extended-release solid dispersions of nonsteroidal antiinflammatory drugs with aqueous polymeric dispersions: optimization of drug release via a curve-fitting technique |
| Q42922743 | Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability |
| Q46722927 | Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique |
| Q40303962 | Development, characterization and solubility study of solid dispersions of Cefuroxime Axetil by the solvent evaporation method |
| Q40304480 | Development, characterization and solubility study of solid dispersions of azithromycin dihydrate by solvent evaporation method |
| Q66973909 | Differential Thermal, Solubility, and aging Studies on various Sources of Digoxin and Digitoxin Powder: Biopharmaceutical Implications |
| Q41988865 | Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing |
| Q42067721 | Dissolution enhancement of glimepiride using modified gum karaya as a carrier |
| Q37360541 | Dissolution improvement of high drug-loaded solid dispersion |
| Q77187583 | Dissolution kinetics for coprecipitates of diflunisal with PVP K30 |
| Q39205292 | Dissolution of solid dispersions: the glutethimide-Renex 650 melt system |
| Q43698736 | Dissolution properties and anticonvulsant activity of phenytoin-polyethylene glycol 6000 and -polyvinylpyrrolidone K-30 solid dispersions. |
| Q47227688 | Dissolution properties of piroxicam powders and capsules as a function of particle size and the agglomeration of powders |
| Q46985265 | Dissolution properties of praziquantel--PVP systems |
| Q46379350 | Dissolution properties of praziquantel-beta-cyclodextrin systems |
| Q43296465 | Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions. |
| Q45953237 | Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers. |
| Q51363069 | Dissolution rate enhancement, in vitro evaluation and investigation of drug release kinetics of chloramphenicol and sulphamethoxazole solid dispersions. |
| Q72654817 | Dissolution, Stability, and Absorption Characteristics of Dicumarol in Polyethylene Glycol 4000 Solid Dispersions |
| Q46644174 | Dissolution, solubility, XRD, and DSC studies on flurbiprofen-nicotinamide solid dispersions |
| Q37703241 | Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility |
| Q37927093 | Drug delivery strategies for poorly water-soluble drugs: the industrial perspective |
| Q41885580 | Drug solubility: importance and enhancement techniques |
| Q39924081 | Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy |
| Q93345097 | Effect of Particle Size and Polymer Loading on Dissolution Behavior of Amorphous Griseofulvin Powder |
| Q42178091 | Effect of Sulindac Binary System on In Vitro and In Vivo Release Profiles: An Assessment of Polymer Type and Its Ratio |
| Q68489978 | Effect of Vehicle Amphiphilicity on the Dissolution and Bioavailability of a Poorly Water-Soluble Drug from Solid Dispersions |
| Q42927549 | Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets. |
| Q44688209 | Effect of excipients on dissolution enhancement of aceclofenac solid dispersions studied using response surface methodology: a technical note |
| Q37360630 | Effect of hydrophilic swellable polymers on dissolution enhancement of carbamazepine solid dispersions studied using response surface methodology |
| Q57382808 | Effect of storage conditions on the recrystallization of drugs in solid dispersions with crospovidone |
| Q43266615 | Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions |
| Q52375028 | Effects of surfactants on amiodarone intestinal absorption. I. Sodium laurylsulfate. |
| Q61796625 | Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy |
| Q51454727 | Electrolyte-stimulated biphasic dissolution profile and stability enhancement for tablets containing drug-polyelectrolyte complexes. |
| Q61813784 | Engineering of Nanofibrous Amorphous and Crystalline Solid Dispersions for Oral Drug Delivery |
| Q38534493 | Enhanced Dissolution and Oral Bioavailability of Piroxicam Formulations: Modulating Effect of Phospholipids |
| Q34158858 | Enhanced dissolution and stability of Tanshinone IIA base by solid dispersion system with nano-hydroxyapatite |
| Q43844886 | Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent |
| Q35168690 | Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation |
| Q73504298 | Enhanced release of solid dispersions of etodolac in polyethylene glycol |
| Q46418404 | Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique |
| Q50909677 | Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems. |
| Q74065444 | Enhancement of dissolution and bioavailability of piroxicam in solid dispersion systems |
| Q43669967 | Enhancement of dissolution of ethopropazine using solid dispersions prepared with phospholipid and/or polyethylene glycol |
| Q41919742 | Enhancement of dissolution profile by solid dispersion (kneading) technique |
| Q45260301 | Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. |
| Q53241631 | Enhancement of solubility and dissolution of cilostazol by solid dispersion technique. |
| Q47916217 | Enhancement of solubility and oral bioavailability of manidipine by formation of ternary solid dispersion with d-α-tocopherol polyethylene glycol 1000 succinate and copovidone. |
| Q50799182 | Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions. |
| Q46313976 | Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. |
| Q46339838 | Estimation of drug solubility in polymers via differential scanning calorimetry and utilization of the fox equation |
| Q46634921 | Eutectic formation analysis of amino acid mixtures using molecular dynamics simulations |
| Q44122680 | Eutectics as improved pharmaceutical materials: design, properties and characterization |
| Q84965960 | Evaluation of Predictive Models for Stable Solid Solution Formation |
| Q41989583 | Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion. |
| Q37183352 | Evaluation of Three Amorphous Drug Delivery Technologies to Improve the Oral Absorption of Flubendazole |
| Q30540120 | Evaluation of colloidal solid dispersions: physiochemical considerations and in vitro release profile |
| Q44120624 | Evaluation of controlled-release polar lipid microparticles |
| Q41989095 | Evaluation of griseofulvin binary and ternary solid dispersions with HPMCAS. |
| Q42172155 | Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine |
| Q44555143 | Evaluation of polar lipid-hydrophilic polymer microparticles |
| Q44277719 | Evaluation of solid dispersion particles prepared with SEDS. |
| Q91810738 | Evaluation of the bioavailability of hydrocortisone when prepared as solid dispersion |
| Q57345919 | Excipients That Facilitate Amorphous Drug Stabilization |
| Q44388478 | Factors affecting the apparent solubility of ursodeoxycholic acid in the grinding process |
| Q58802630 | Fast Dissolving of Ferulic Acid via Electrospun Ternary Amorphous Composites Produced by a Coaxial Process |
| Q93037390 | Fifty-Eight Years and Counting: High-Impact Publishing in Computational Pharmaceutical Sciences and Mechanism-Based Modeling |
| Q83201588 | Fluidity and tableting characteristics of a powder solid dispersion of the low melting drugs ketoprofen and ibuprofen with crospovidone |
| Q74533966 | Flurbiprofen-loaded nanospheres: analysis of the matrix structure by thermal methods |
| Q85560544 | Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan |
| Q60927375 | Formulation and clinical investigation of optimized vinpocetine lyoplant-tabs: new strategy in development of buccal solid dosage form |
| Q41906019 | Formulation and evaluation of fixed-dose combination of bilayer gastroretentive matrix tablet containing atorvastatin as fast-release and atenolol as sustained-release. |
| Q41990098 | Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion |
| Q41848183 | Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems. |
| Q35125581 | Formulation of immediate release pellets containing famotidine solid dispersions |
| Q41989380 | Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR. |
| Q38098512 | Formulation strategies for drug delivery of tacrolimus: An overview |
| Q46389132 | Formulation studies and in vivo evaluation of a flurbiprofen-hydroxypropyl beta-cyclodextrin system |
| Q26822873 | Fundamental aspects of solid dispersion technology for poorly soluble drugs |
| Q57158361 | High-Throughput Raman Spectroscopy Screening of Excipients for the Stabilization of Amorphous Drugs |
| Q44461285 | Highly stabilized amorphous 3-bis(4-methoxyphenyl)methylene-2-indolinone (TAS-301) in melt-adsorbed products with silicate compounds |
| Q57340445 | Hot Melt Extrusion: A Process Overview and Use in Manufacturing Solid Dispersions of Poorly Water-Soluble Drugs |
| Q46279576 | Hydrogen Bonding: Between Strengthening the Crystal Packing and Improving Solubility of Three Haloperidol Derivatives. |
| Q44234014 | Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules |
| Q73357631 | Identification of drugs in pharmaceutical dosage forms by X-ray powder diffractometry |
| Q90667750 | Impact of Hot-Melt Extrusion Processing Conditions on Physicochemical Properties of Amorphous Solid Dispersions Containing Thermally Labile Acrylic Copolymer |
| Q94469561 | Impact of hypromellose acetate succinate grade on drug amorphous solubility and in vitro membrane transport |
| Q46185895 | Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives |
| Q41916465 | Improved dissolution of oleanolic acid with ternary solid dispersions |
| Q44694744 | Improvement of dissolution and bioavailability of nitrendipine by inclusion in hydroxypropyl-beta-cyclodextrin |
| Q42114476 | Improvement of solubility and dissolution rate of indomethacin by solid dispersions in Gelucire 50/13 and PEG4000. |
| Q72209681 | Improvement of the diuretic effect of triamterene via solid dispersion technique with PEG 4000 |
| Q44139664 | Improving the dissolution and bioavailability of nifedipine using solid dispersions and solubilizers |
| Q35829960 | In situ absorption in rat intestinal tract of solid dispersion of annonaceous acetogenins |
| Q33205350 | In vitro and in vivo evaluation of glibenclamide in solid dispersion systems |
| Q40432062 | In vitro dissolution study of atorvastatin binary solid dispersion |
| Q42152991 | In vitro-in vivo evaluation of fast-dissolving tablets containing solid dispersion of pioglitazone hydrochloride |
| Q51489561 | In vitro/in vivo correlation of fast release mephenamic acid microspheres in humans. |
| Q42840452 | In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier. |
| Q73213866 | Inclusion of ketoprofen with skimmed milk by freeze-drying |
| Q36337318 | Influence of Hydroxypropyl Methylcellulose on Metronidazole Crystallinity in Spray-Congealed Polyethylene Glycol Microparticles and Its Impact with Various Additives on Metronidazole Release |
| Q47172259 | Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions |
| Q44961494 | Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system |
| Q42104195 | Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction |
| Q32079726 | Interactions between carbamazepine and polyethylene glycol (PEG) 6000: characterisations of the physical, solid dispersed and eutectic mixtures |
| Q46732386 | Interactive mixture as a rapid drug delivery system |
| Q45349527 | Investigation into mixing capability and solid dispersion preparation using the DSM Xplore Pharma Micro Extruder |
| Q87666677 | Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion |
| Q93943384 | Investigation of dissolution enhancement of itraconazole by solid dispersion in superdisintegrants |
| Q48235393 | Investigation of phase diagrams and physical stability of drug-polymer solid dispersions |
| Q42387875 | Investigation on in vitro dissolution rate enhancement of indomethacin by using a novel carrier sucrose fatty acid ester |
| Q41892318 | Kneading technique for preparation of binary solid dispersion of meloxicam with poloxamer 188. |
| Q37781831 | Liquisolid technology for dissolution rate enhancement or sustained release |
| Q50279753 | Mechanical Properties and Tableting Behavior of Amorphous Solid Dispersions. |
| Q45711832 | Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage |
| Q44217503 | Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions |
| Q73755716 | Melt extrusion--an alternative method for enhancing the dissolution rate of 17beta-estradiol hemihydrate |
| Q34793080 | Melt extrusion: from process to drug delivery technology |
| Q73515574 | Methods of studying aging and stabilization of spray-congealed solid dispersions with carnauba wax. 1. Microcalorimetric investigation |
| Q44353177 | Microcrystals for dissolution rate enhancement of poorly water-soluble drugs |
| Q30583709 | Microwave-induced solid dispersion technology to improve bioavailability of glipizide. |
| Q46688318 | Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection. |
| Q35209956 | Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acid |
| Q58691096 | Nanotechnologies for Curcumin: An Ancient Puzzler Meets Modern Solutions |
| Q111348785 | Nematicidal effects of piperine on the pinewood nematode Bursaphelenchus xylophilus |
| Q36662432 | Nonlinear optical imaging for sensitive detection of crystals in bulk amorphous powders. |
| Q90461771 | Optimization of the Production Process and Product Quality of Titanate Nanotube-Drug Composites |
| Q38082728 | Oral anticancer drugs: mechanisms of low bioavailability and strategies for improvement. |
| Q37910262 | Oral formulation strategies to improve solubility of poorly water-soluble drugs |
| Q36950034 | Pharmaceutical applications of hot-melt extrusion: part I. |
| Q39124475 | Pharmaceutical development and optimization of azithromycin suppository for paediatric use. |
| Q48384525 | Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies |
| Q39293659 | Physical Properties of Betamethasone Alcohol-Polyethylene Glycol 6000 Solid Dispersions |
| Q93945979 | Physical properties of solid dispersion of a nonsteroidal anti-inflammatory drug (M-5011) with Eudragit E |
| Q73203971 | Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization |
| Q38257177 | Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach. |
| Q59285781 | Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30 |
| Q44437237 | Physicochemical Characterization and Drug Release Studies of Nilvadipine Solid Dispersions Using Water-Insoluble Polymer as a Carrier |
| Q53460929 | Physicochemical characterization and in vivo evaluation of flurbiprofen-loaded solid dispersion without crystalline change. |
| Q78056704 | Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000 |
| Q44861006 | Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. |
| Q41739305 | Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. |
| Q45954897 | Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188. |
| Q46985881 | Physicochemical, pharmacokinetic and pharmacodynamic evaluations of novel ternary solid dispersion of rebamipide with poloxamer 407. |
| Q42927794 | Physiochemical Characterization and Release Rate Studies of SolidDispersions of Ketoconazole with Pluronic F127 and PVP K-30. |
| Q88959622 | Poly(2-Ethyl-2-Oxazoline) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs |
| Q38818237 | Polyethylene glycol (PEG): a versatile polymer for pharmaceutical applications |
| Q57340433 | Polymers and Biopolymers in Pharmaceutical Technology |
| Q52666349 | Prediction of Phase Behavior of Spray-Dried Amorphous Solid Dispersions: Assessment of Thermodynamic Models, Standard Screening Methods and a Novel Atomization Screening Device with Regard to Prediction Accuracy. |
| Q40648426 | Prediction of poly(ethylene) glycol-drug eutectic compositions using an index based on the van't Hoff equation |
| Q90066893 | Preparation and Characterization of Poloxamer 407 Solid Dispersions as an Alternative Strategy to Improve Benznidazole Bioperformance |
| Q73450736 | Preparation and characterization of Furosemide-Eudragit controlled release systems |
| Q42411627 | Preparation and characterization of cefuroxime axetil solid dispersions using hydrophilic carriers |
| Q41990256 | Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique |
| Q36080528 | Preparation and characterization of solid dispersion freeze-dried efavirenz - polyvinylpyrrolidone K-30 |
| Q34976552 | Preparation and characterization of solid dispersions of carvedilol with PVP K30 |
| Q77187592 | Preparation and dissolution rate of gliquidone-PVP K30 solid dispersions |
| Q42948121 | Preparation and evaluation of fast-release mephenamic acid microspheres. |
| Q36882074 | Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept |
| Q43151735 | Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique |
| Q43906253 | Preparation and in vitro evaluation of solid dispersions of halofantrine |
| Q41952701 | Preparation and in vitro evaluation of solid dispersions of total flavones of Hippophae rhamnoides L. |
| Q86823001 | Preparation and physicochemical characterization of a solid dispersion of (3, 5, 6-trimethylpyrazin-2-yl) methyl 3-methoxy-4-[(3, 5, 6-trimethylpyrazin-2-yl) methoxy] benzoate (VA-T) and polyvinylpyrrolidone |
| Q48110169 | Preparation and valuation of a topical solution containing eutectic mixture of itraconazole and phenol |
| Q44193644 | Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract. |
| Q35844610 | Preparation of evodiamine solid dispersions and its pharmacokinetics |
| Q43845789 | Preparation of extruded carbamazepine and PEG 4000 as a potential rapid release dosage form |
| Q42880736 | Preparation, Characterization and Pharmacodynamic Evaluation of Fused Dispersions of Simvastatin using PEO-PPO Block Copolymer |
| Q53637145 | Preparation, in-vitro and in-vivo evaluation of spray-dried ternary solid dispersion of biopharmaceutics classification system class II model drug. |
| Q41913846 | Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug |
| Q43768925 | Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability |
| Q44437230 | Processing of Nimesulide-PEG 400-PG-PVP Solid Dispersions: Preparation, Characterization, and In Vitro Dissolution |
| Q74017388 | Properties of citric acid at the glass transition |
| Q59234241 | Properties of the Sodium Naproxen-Lactose-Tetrahydrate Co-Crystal upon Processing and Storage. |
| Q57145360 | Qualitative and Quantitative Characterization of Composition Heterogeneity on the Surface of Spray Dried Amorphous Solid Dispersion Particles by an Advanced Surface Analysis Platform with High Surface Sensitivity and Superior Spatial Resolution |
| Q41509930 | Rapid assessment of homogeneity and stability of amorphous solid dispersions by atomic force microscopy--from bench to batch |
| Q57351446 | Recrystallization of Nifedipine and Felodipine from Amorphous Molecular Level Solid Dispersions Containing Poly(vinylpyrrolidone) and Sorbed Water |
| Q38206296 | Refining stability and dissolution rate of amorphous drug formulations |
| Q57353028 | Review: Use of Thermal, Diffraction, and Vibrational Analytical Methods to Determine Mechanisms of Solid Dispersion Stability |
| Q37643840 | Review: physical chemistry of solid dispersions |
| Q40177847 | Rifampin Stability and Solution Concentration Enhancement Through Amorphous Solid Dispersion in Cellulose ω-Carboxyalkanoate Matrices |
| Q48245421 | Role of viscosity in influencing the glass-forming ability of organic molecules from the undercooled melt state |
| Q35938971 | Second-order nonlinear optical imaging of chiral crystals |
| Q38175527 | Selecting oral bioavailability enhancing formulations during drug discovery and development. |
| Q53722324 | Selection of excipients for melt extrusion with two poorly water-soluble drugs by solubility parameter calculation and thermal analysis. |
| Q39293663 | Solid Dispersions of Drugs in Polyoxyethylene 40 Stearate: Dissolution Rates and Physico-Chemical Interactions |
| Q39175933 | Solid dispersion approach for overcoming bioavailability problems due to polymorphism of nabilone, a cannabinoid derivative |
| Q38475312 | Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability |
| Q33748142 | Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs |
| Q45328345 | Solid dispersion tablets of breviscapine with polyvinylpyrrolidone K30 for improved dissolution and bioavailability to commercial breviscapine tablets in beagle dogs. |
| Q44084018 | Solid dispersions of diflunisal-PVP: polymorphic and amorphous states of the drug |
| Q37932560 | Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs |
| Q41122622 | Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions |
| Q43916006 | Solid-state characterization of nifedipine solid dispersions |
| Q74017423 | Solid-state characterization of paclitaxel |
| Q72935908 | Solid-state emulsions: the effects of process and storage conditions |
| Q36112246 | Solubility Enhancement of Budesonide and Statistical Optimization of Coating Variables for Targeted Drug Delivery |
| Q44598171 | Solubility advantage from amorphous etoricoxib solid dispersions |
| Q40585993 | Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers |
| Q71729154 | Solubility behavior, phase transition, and structure-based nucleation inhibition of etanidazole in aqueous solutions |
| Q43731643 | Solubility of solid dispersions of pizotifen malate and povidone |
| Q59235328 | Solvent change co-precipitation with hydroxypropyl methylcellulose phthalate to improve dissolution characteristics of a poorly water-soluble drug |
| Q39099061 | Some effects of urea on drug dissolution |
| Q39099210 | Some factors influencing dissolution from salicylic acid-urea solid dispersions |
| Q52528966 | Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. |
| Q32095025 | Spectroscopic identification of an amorphous-to-crystalline drug transition in a solid dispersion SCH 48461 capsule formulation |
| Q90310800 | Spray Congealing: An Emerging Technology to Prepare Solid Dispersions with Enhanced Oral Bioavailability of Poorly Water Soluble Drugs |
| Q38213463 | Spray-congealed microparticles for drug delivery - an overview of factors influencing their production and characteristics |
| Q73367826 | Stability characterization of controlled release coprecipitates and solid dispersions |
| Q74372282 | Stabilization of amorphous indomethacin by co-grinding in a ternary mixture |
| Q42102623 | Studies on dissolution enhancement of prednisolone, a poorly water-soluble drug by solid dispersion technique |
| Q90289393 | Study of Gliclazide Solid Dispersion Systems Using PVP K-30 and PEG 6000 by Solvent Method |
| Q53542335 | Sugars as solid dispersion carrier to improve solubility and dissolution of the BCS class II drug: clotrimazole. |
| Q86182798 | Supersolubilization and amorphization of a model basic drug, haloperidol, by interaction with weak acids |
| Q52614621 | Synthesis, characterization, and stability study of desloratadine multicomponent crystal formation. |
| Q45111973 | Tableting of Eudragit RS and propranolol hydrochloride solid dispersion: effect of particle size, compaction force, and plasticizer addition on drug release. |
| Q37854665 | Technology evaluation: Kollicoat IR. |
| Q74017399 | Testosterone skin permeation enhancement by menthol through formation of eutectic with drug and interaction with skin lipids |
| Q90416286 | The Effect of Inorganic Salt on Disintegration of Tablets with High Loading of Amorphous Solid Dispersion Containing Copovidone |
| Q91847093 | The Improved Cargo Loading and Physical Stability of Ibuprofen Orodispersible Film: Molecular Mechanism of Ion-Pair Complexes on Drug-Polymer Miscibility |
| Q39317255 | The Need for Restructuring the Disordered Science of Amorphous Drug Formulations |
| Q91758332 | The Preparation of Curcumin Sustained-Release Solid Dispersion by Hot Melt Extrusion-Ⅰ. Optimization of the Formulation |
| Q64077469 | The Self-Assembly Phenomenon of Poloxamers and Its Effect on the Dissolution of a Poorly Soluble Drug from Solid Dispersions Obtained by Solvent Methods |
| Q39494609 | The Use of Binary Polymeric Networks in Stabilizing Polyethylene Oxide Solid Dispersions |
| Q51125885 | The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers. |
| Q42927321 | The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions |
| Q39175769 | The effect of composition and ageing on the dissolution rates of chlorpropamide-urea solid dispersions |
| Q70749345 | The effect of incorporation of indomethacin with polyethylene glycol 6000 in a solid dispersion on its in vivo properties in the rat |
| Q44555160 | The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials |
| Q44008111 | The effect of temperature on hydrogen bonding in crystalline and amorphous phases in dihydropyrine calcium channel blockers. |
| Q78139100 | The effects of absorbed water on the properties of amorphous mixtures containing sucrose |
| Q72989404 | The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment |
| Q43025396 | The influence of drug physical state on the dissolution enhancement of solid dispersions prepared via hot-melt extrusion: a case study using olanzapine. |
| Q34469709 | The mechanisms of drug release from solid dispersions in water-soluble polymers |
| Q68853624 | The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method |
| Q38870191 | The role of the carrier in the formulation of pharmaceutical solid dispersions. Part I: crystalline and semi-crystalline carriers |
| Q40030770 | The status and future of chemical microscopy |
| Q93929681 | The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA50 microparticles |
| Q40294237 | Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. |
| Q41507613 | Thermal Characterization of Citric Acid Solid Dispersions with Benzoic Acid and Phenobarbital |
| Q59285745 | Thermal characterization of the antiviral drug UC-781 and stability of its glass |
| Q86836360 | Thermal stability of mefruside-polyvinylpyrrolidone solid dispersions |
| Q36596661 | Thermodynamics of dissolution and infrared-spectroscopy of solid dispersions of phenacetin |
| Q57005044 | Ultrasound-compacted and spray-congealed indomethacin/polyethyleneglycol systems |
| Q33683206 | Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles |
| Q83461108 | Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu |
| Q49179365 | Validation of a liquid chromatographic method for the pharmaceutical quality control of products containing elacridar |
| Q42646407 | Wetting Kinetics: an Alternative Approach Towards Understanding the Enhanced Dissolution Rate for Amorphous Solid Dispersion of a Poorly Soluble Drug |
Search more.